Streetbeat News

Price Targets

HXL

Morgan Stanley analyst Kristine Liwag has maintained an Equal-Weight rating on Hexcel (NYSE:HXL) and reduced the price target from $73 to $70.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:13 pm

GEN

Morgan Stanley analyst Hamza Fodderwala has maintained an Overweight rating on Gen Digital (NASDAQ:GEN) and increased the price target from $28 to $30.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:12 pm

LHX

UBS analyst Myles Walton has maintained a Neutral rating on L3Harris Technologies (NYSE:LHX) and increased the price target from $222 to $229.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:11 pm

CL

Morgan Stanley analyst Dara Mohsenian has maintained an Overweight rating on Colgate-Palmolive (NYSE:CL) and increased the price target from $85 to $93.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:11 pm

LEVI

UBS analyst Joseph Parkhill has maintained a Buy rating on Levi Strauss (NYSE:LEVI) and increased the price target from $21 to $23.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:08 pm

AMP

Morgan Stanley analyst Michael Cyprys has maintained an Equal-Weight rating on Ameriprise Financial (AMP) and increased the price target from $394 to $400.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:02 pm

IR

UBS analyst Markus Mittermaier has reaffirmed a Buy rating on Ingersoll Rand (NYSE:IR) and increased the price target from $78 to $93, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:01 pm

CTVA

Eight analysts have recently updated their ratings on Corteva (NYSE:CTVA), with a mix of bullish and indifferent stances. The average 12-month price target is now $51.2, down from $60.70, with a high estimate of $64.00 and a low of $2.59. Analysts have lowered their price targets, reflecting changes in market dynamics and company performance. Corteva, an agriculture company, has seen a -6.73% decline in revenue growth and has below-average net margins and ROE/ROA, but a favorable debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 4:00 pm

BKU

BankUnited (NYSE:BKU) received mixed analyst ratings with 2 neutral and 2 sell ratings in the past three months. The average 12-month price target is $29.25, up from the previous $28.67. Wedbush's David Chiaverini lowered his target to $31 from $34, Wells Fargo's Steven Shaw raised his to $28 from $26, UBS's Brody Preston set a target of $29, and Goldman Sachs's Ryan Nash raised his to $29 from $26. BankUnited is a regional bank with challenges in market capitalization, revenue growth, net margin, ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 4:00 pm

PFE

Pfizer Inc. (NYSE:PFE) is anticipated to report a Q4 loss of 22 cents per share compared to the previous year's earnings of $1.14 per share, with expected revenue of $14.43 billion versus $24.29 billion in the same quarter last year. The company's shares closed at $27.47. Analysts have recently adjusted Pfizer's price targets, with changes ranging from a downgrade to maintaining ratings but lowering price targets. The most accurate analysts have accuracy rates between 64% and 76%.

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 4:00 pm